Back to Search Start Over

P2.01-01 Initial Result of the ImmunoPET Phase1 Study: Characterising PD-L1 During Chemoradiotherapy with 89Zr- Durvalumab (MEDI4736) PET/CT.

Authors :
Hegi-Johnson, F.
Rudd, S.
Roselt, P.
Wichmann, C.
Sursock, S.
Akhurst, T.
Jackson, P.
Hicks, R.
Scott, A.
Donnelly, P.
John, T.
MacManus, M.
Source :
Journal of Thoracic Oncology; 2023 Supplement, Vol. 18 Issue 11, pS295-S295, 1p
Publication Year :
2023

Details

Language :
English
ISSN :
15560864
Volume :
18
Issue :
11
Database :
Complementary Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Academic Journal
Accession number :
173323100
Full Text :
https://doi.org/10.1016/j.jtho.2023.09.506